Company profile
TC BioPharm company profile
TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors. TC BioPharm’s mission is to develop and commercialize innovative cell-based products to treat disease, improving patient health and quality of life. TC BioPharm is a clinical development company with a cell-based product pipeline capable of treating a variety of disorders, including cancer and severe viral infections. TCB is currently conducting Phase II/III clinical studies of its lead product, ImmuniCell, in renal cell cancinoma, non-small cell lung cancer and melanoma patients.
Business identity
- Website
- http://www.tcbiopharm.com/
- Contact email
- [email protected]
- Phone number
- +4401414337557
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $0-$1M
- Founded
- 2013-01-01, Year
Headquarters
- Headquarters
- Holytown, Scotland, United Kingdom
- Postal code
- ML1 4WQ
- Country code
- GB
- Continent
- Europe